Trials / Conditions / Undifferentiated Pleomorphic Sarcoma (UPS)
Undifferentiated Pleomorphic Sarcoma (UPS)
5 registered clinical trials studyying Undifferentiated Pleomorphic Sarcoma (UPS) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sa NCT07169344 | Oslo University Hospital | Phase 2 |
| Recruiting | Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarc NCT07173972 | Oslo University Hospital | Phase 2 |
| Recruiting | A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors NCT06789172 | Epkin | Phase 1 |
| Withdrawn | Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanc NCT06370871 | Boehringer Ingelheim | Phase 3 |
| Active Not Recruiting | Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subj NCT05827614 | Boundless Bio, Inc. | Phase 1 |